Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
86.19
+0.41 (0.48%)
At close: Dec 5, 2025, 4:00 PM EST
86.00
-0.19 (-0.22%)
After-hours: Dec 5, 2025, 7:01 PM EST
Edwards Lifesciences Employees
Edwards Lifesciences had 15,800 employees as of December 31, 2024. The number of employees decreased by 4,000 or -20.20% compared to the previous year.
Employees
15,800
Change (1Y)
-4,000
Growth (1Y)
-20.20%
Revenue / Employee
$372,392
Profits / Employee
$86,576
Market Cap
50.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15,800 | -4,000 | -20.20% |
| Dec 31, 2023 | 19,800 | 2,500 | 14.45% |
| Dec 31, 2022 | 17,300 | 1,600 | 10.19% |
| Dec 31, 2021 | 15,700 | 800 | 5.37% |
| Dec 31, 2020 | 14,900 | 1,000 | 7.19% |
| Dec 31, 2019 | 13,900 | 1,100 | 8.59% |
| Dec 31, 2018 | 12,800 | 600 | 4.92% |
| Dec 31, 2017 | 12,200 | 1,100 | 9.91% |
| Dec 31, 2016 | 11,100 | 1,300 | 13.27% |
| Dec 31, 2015 | 9,800 | 700 | 7.69% |
| Dec 31, 2014 | 9,100 | 500 | 5.81% |
| Dec 31, 2013 | 8,600 | 400 | 4.88% |
| Dec 31, 2012 | 8,200 | 400 | 5.13% |
| Dec 31, 2011 | 7,800 | 800 | 11.43% |
| Dec 31, 2010 | 7,000 | 600 | 9.38% |
| Dec 31, 2009 | 6,400 | 200 | 3.23% |
| Dec 31, 2008 | 6,200 | 600 | 10.71% |
| Dec 31, 2007 | 5,600 | 50 | 0.90% |
| Dec 31, 2006 | 5,550 | 150 | 2.78% |
| Dec 31, 2005 | 5,400 | 200 | 3.85% |
| Dec 31, 2004 | 5,200 | 200 | 4.00% |
| Dec 31, 2003 | 5,000 | 0 | - |
| Dec 31, 2002 | 5,000 | 189 | 3.93% |
| Dec 31, 2001 | 4,811 | -289 | -5.67% |
| Dec 31, 2000 | 5,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EW News
- 1 day ago - Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference - Business Wire
- 5 days ago - HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 15 days ago - Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits - Seeking Alpha
- 26 days ago - Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease - Business Wire
- 5 weeks ago - Edwards Lifesciences Corporation (EW) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Edwards Lifesciences beats quarterly estimates on strength in heart devices - Reuters
- 5 weeks ago - Edwards Lifesciences CFO Scott Ullem to step down by mid-2026 - Reuters
- 5 weeks ago - Edwards Lifesciences Announces CFO Transition Plan - Business Wire